Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jun 13;2:PO.17.00241. doi: 10.1200/PO.17.00241

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 by American Society of Clinical Oncology

Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

Fig 4. — (A-C) Kaplan-Meier plots of patients with (A) CD8-high versus CD8-low stage II and III disease in the Colorectal Cancer Intrinsic Subtype (CRIS) -C surgery-only, taxonomy cohort; (B) CD3-high versus CD3-low stage II and III disease in the CRIS-C surgery-only, taxonomy cohort; and (C) CD8-high versus CD8-low stage II disease in the CRIS-C surgery-only, taxonomy cohort. Patients were split into high (blue) and low (gold) CD8 or CD3 groups using the median as cutoff. Significance was assessed using a log-rank test. (D) Diagram of a potential decision tree for treatment of patients with stage II disease in the CRIS-C cohort. CMS2, consensus molecular subtype 2; FU, fluorouracil; IHC, immunohistochemistry.